Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas

By Stroppa Elisa   Bertuzzi Alexia   Comite Gabriele   Mussi Chiara   Lutman Romano   Barbato Alfredo   Santoro Armando  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 834-838

Springer Publishing Company

Access to resources Recommend Favorite

Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx^®) in combination with topotecan in patients with advanced malignancies

By Ghesquières Hervé   Faivre Sandrine   Djafari Latifa   Pautier Patricia   Lhommé Catherine   Lozahic Stéphanie   Djazouli Kamel   Armand Jean-Pierre   Raymond Eric  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 413-421

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of continuous infusion cilengitide in patients with solid tumors

By O'Donnell Peter  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 604-610

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study

By Schmid Peter   Schweigert Marcus   Beinert Thomas   Flath Bernd   Sezer Orhan   Possinger Kurt  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 139-146

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study

By Davies Angela   Ho Cheryl   Hesketh Paul   Beckett Laurel   Lara Primo   Lau Derick   Gandara David  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 351-355

Springer Publishing Company

Access to resources Recommend Favorite